HUAYAN ROBOTICS
| Register Close | 2026/03/25 IPO Closing in 5 Days |
| Listing Date | 2026/03/30 |
| Register Close | 2026/03/25 IPO Closing in 5 Days |
| Listing Date | 2026/03/30 |
Guangdong Huayan Robotics Co. is a collaborative robotics company engaged in the development, manufacturing and sale of collaborative robots (cobots) and core motion components for industrial automation applications. The Group primarily sold its robot hardware to customers in Chinese Mainland, Europe, the Americas and other regions in Asia.
--
The Group’s cobot portfolio comprises two primary product lines — the E Series and the S Series. E Series cobots are primarily used in industrial manufacturing, consumer electronics and healthcare, supporting high-precision applications such as micro-component assembly, precision machining and medical testing. The S Series cobots are mainly deployed in the automotive and logistics sectors, including applications such as palletizing, machine tending, material handling and logistics automation.
--
As of March 10, 2026, the Group had achieved the successful commercialization of two major cobot series and all core motion component products. According to the report, the Group was the second largest cobot company in China with a 10.3% share and a top five global player with 3.5% share in 2024.
--
The Group’s customers primarily include system integrators, end users and distributors, who are mainly industrial automation solution providers and equipment manufacturers across sectors including cognitive robotics, semiconductors, genetic sequencing, power batteries and consumer electronics. The Group manufactured its products primarily at its production facility in Foshan, Guangdong, and also operate a production facility in Shenzhen, Guangdong, which is primarily responsible for the production of its R&D samples.
| Market | Hong Kong (Main Board) |
| Business Nature | Industrials |
| Major Business Area | China |
| Board Lot | 200 |
| No. of Offer Shares | 80.79M H shares |
| No. of International Offer Shares | 76.75M H shares |
| No. of HK Offer Shares | 4.04M H shares |
| Offer Price | $17.00 |
| Stock Code | 1021 |
| Sponsor(s) | China International Capital Corporation Hong Kong Securities Limited, Deutsche Securities Asia Limited |
| Underwriter(s) | China International Capital Corporation Hong Kong Securities Limited, Deutsche Bank AG, Hong Kong Branch, Futu Securities International (Hong Kong) Limited, Zheshang International Financial Holdings Co., Limited |
| Application Period | Mar 20 (Fri) - noon, Mar 25 (Wed) |
| Price Determination Date | -- |
| Result Announcement Date | On or before Mar 27 (Fri) |
| Result Announcement Date | On or before Mar 27 (Fri) |
| Result Announcement Date | On or before Mar 30 (Mon) |
| Dealings in Shares commence on | Mar 30, 2026. (Mon) |
| Offer Price | $17.00 |
| Capitalization (H Shares) | 8.73B |
| NAV / share ($) | $3.56 (Unaudited pro forma adj NAV / share) |
| Assuming the offer price being at HKD 17.00, the net proceeds raised would be HKD 1.28B, of which |
| 55% : Deepening R&D capabilities |
| 20% : Global business development to strengthen market leadership |
| 15% : Upgrading and expanding production capabilities |
| 10% : Working capital |
| Prospectus |
| Remark: | The above information is referenced from the prospectus. |
| All data is calculated from the non- exercise rights(if applicable). |
| Currency | : |
| Listing Price | : |
| Board Lot | : |
| Admission Fee* |
: |
| Subscribing Lot | : |
| Subscribing Fee | : |
| Subscribing Amount | : |